As of August 28, 2026, Sutro Biopharma, Inc. (STRO) has a DilutionWatch DilutionScore of 49/100, rated MEDIUM dilution risk. Sutro Biopharma, Inc. has a market capitalization of $484.35M, 16.58M shares outstanding, 12 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise
model 15%
• Under 12 months cash (8mo)
Market Data
Market Cap$484.35M
Shares Outstanding16.58M
Float10.30M
Cash$164.35M
Debt$4.06M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 367.3% shares (2026Q1 vs prior)
12 institutional holders · 1.99M shares
#1
BARCLAYS PLC
1.40M shares
#2
Merck & Co., Inc.
272.4K shares
#3
MORGAN STANLEY
241.9K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest1.74M
Days to Cover6.3
% of Float16.9%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2018-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual STRO Dilution Snapshot
Sutro Biopharma, Inc. (STRO) has a DilutionScore of 49/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for STRO: xbrl on 2018-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track STRO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking STRO — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for STRO
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.